Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KLOW RiskPositive

KYNTRA BIO, INC.

A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.

kyntrabio.com
Filed: Sep 30, 2026San Francisco, CaliforniaCIK: 0000921299Health Care
Full company profileView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Kyntra Bio appointed Andrew E. Singer, an investment banking executive with biopharma expertise, as a Class III director and Audit Committee member effective October 1, 2026. This board expansion strengthens governance and strategic guidance for the company's oncology and rare disease focus.

Key Takeaways

Andrew E. Singer appointed as Class III director with term expiring in 2029, bringing investment banking and biopharma strategic expertise

Singer joins the Audit Committee, enhancing financial oversight and governance capabilities

2 more takeaways

Related Filings (1)

1 more filing from KYNTRA BIO, INC. in the last 90 days

Filing Overview

Form Type8-K
Filing DateSep 30, 2026
Item5.02
CategoryExecutive Change
CIK0000921299
Accession #0001193125-26-409819
Risk LevelLOW
SentimentPositive
Signalinformational
Topics
board changeleadership transition

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

KYNTRA BIO, INC. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.